ArticleOncotarget2017

STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.

Trevor J Grant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.